Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-centre, open-label study

International Journal of Antimicrobial Agents · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles